Cite
MLA Citation
Luke Jones et al.. “Preclinical activity of the antibody‐drug conjugate denintuzumab mafodotin (SGN‐CD19A) against pediatric acute lymphoblastic leukemia xenografts.” Pediatric blood & cancer, vol. 66, no. 8, 2019, p. n/a. http://access.bl.uk/ark:/81055/vdc_100117761910.0x000013